Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-11-22
Original SEC Filing: Click here

---

Webplus: SVA/20171122/6-K/2_EX-99.1/000.htm SEC Original: tv480143_ex99-1.htm
Sinovac Files 2016 Annual Report on Form 20-F and Reports Unaudited Fourth Quarter 2016 Financial Results Fourth Quarter 2016 Financial highlights Ÿ Quarterly sales from continuing operations were $31.4 million compared to $23.0 million in the prior year period, an increase of 36.7%. Sales increased primarily due to revenue generated by the Company’s EV71 vaccine. Ÿ Net income attributable to

---

---

Webplus: SVA/20171122/6-K/1/000.htm SEC Original: tv480143_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-11-22CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085